-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Cervical vertebral disease can be divided into cervical type, nerve root type, spinal cord type, other type (vertebral artery type, sympathetic type).
spinal spinal cervical vertebral disease (Cervical spondylotic myelopathy, CSM) refers to cervical vertebral disease sepsis, which is the basis of cervical vertebral small joints and intervertebral disc retreats into the basic pathological basis, and which suppresses the spinal cord or the blood vessels that govern the spinal cord, causing the section of the vertebral tube cavity stenosis and causing chronic compression or (and) spinal cord blood supply disorders of the spinal cord and causing spinal cord dysfunction.
at present, the treatment of clinical CSM is still lacking drugs that can effectively control its development and promote the patient's functional recovery.
nonsteroidal anti-inflammatory drugs, glucocorticoids, neurotrophic drugs, surgical intervention is a modern medical CSM conventional treatment method.
the purpose of drug therapy is to control the patient's pain, numbness and other symptoms, and lack of the role of neuropathy. Although the effect of
surgery is more accurate on CSM, there are also deficiencies such as higher postoperative complications and poor functional recovery after reduction of stress.
for the above reasons, seeking further effective and safe intervention of CSM, and the rapid application of clinical treatment methods is the focus of drug research and development.
May 2015, Shanghai and Huang Pharmaceutical Co., Ltd. and Longhua Hospital, affiliated with Shanghai University of Traditional Chinese Medicine, jointly developed six new chinese medicine class ginseng pills.
the clinical value of the development of the new drug lies in the early and medium prevention of spinal cervical vertebral disease and later with surgical treatment to solve local inflammation, ischemia or hemostatic stimulation caused by the continued damage of the spinal cord and other problems, improve clinical efficacy, can fill the current clinical treatment of spinal cervical vertebral disease blank, has important development value and clinical significance.
original title: and Huang Pharmaceuticalco hand in hand with Longhua Hospital: Chinese medicine 6 new drugs ginseng pills approved for clinical trial.